Ara
Toplam kayıt 33, listelenen: 11-20
Evaluation of the Patient Acceptable Symptom State in Patients with Psoriatic Arthritis
(Wiley-Blackwell, 2014)
[No Abstract Available]
Microorganisms isolated in COPD patients hospitalised for acute exacerbations and their clinical correlations
(European Respiratory Soc Journals Ltd, 2012)
[No Abstract Available]
Biological and targeted-synthetic disease-modifying antirheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: Real-life TReasure prospective data
(Clinical and Experimental Rheumatology S.A.S., 2021)
Objective To determine the real-life efficacy, safety, and drug-retention rates of leflunomide (LEF) or methotrexate (MTX) as a synthetic DMARD used in combination with biological DMARDs for rheumatoid arthritis (RA). ...
Prognostic values of various hematological variables as markers of systemic inflammation in metastatic lung cancer
(Wolters Kluwer Medknow Publications, 2020)
Background: Chronic state of inflammation is an important factor in advanced cancer which is used by tumor cells for maintaining survival and growth. Hematological parameters such as neutrophil/lymphocyte ratio (NLR), ...
Convalescent plasma therapy in patients with COVID-19 (Letter)
(Pergamon-Elsevier Science Ltd, 2021)
[No Abstract Available]
Leflunomide as a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid Arthritis
(Wiley, 2018)
[No Abstract Available]
Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study
(Amer Soc Hematology, 2019)
[No Abstract Available]
GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.
(Amer Soc Clinical Oncology, 2019)
[No Abstract Available]
Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data
(Amer Soc Hematology, 2019)
[No Abstract Available]